Skip to main content
. 2022 Jul 27;13:888644. doi: 10.3389/fimmu.2022.888644

Table 1.

Characteristics of the included studies about interleukin levels in patients with OSA and control.

Study ID Region PMID Researched protein P/CNo. NOS
Kotsiou O.S., 2022 Greece 34678476 IL-6 15/15 6
Bhatt S.P., 2021 India 34086720 IL-6, IL-8, IL-10, IL-17, IL-23 190/57 7
Bilal N., 2021 Turkey 32776303 IL-6, IL-8 30/30 8
Cheng J., 2021 China 34488706 IL-8 29/22 6
Chen B., 2021 China 33942365 IL-1β 67/30 8
Celikhisar H., 2020 Turkey 32454912 IL-1β 84/82 8
Chen V.G., 2020 Brazil 30213594 IL-1β, IL-4, IL-6, IL-8, IL-10 17/17 5
Dalesio N.M., 2020 US 31688081 IL-1β, IL-6, IL-10 7/18 5
Huang Y.S., 2020 China 32260590 IL-1β, IL-6, IL-10,
IL-12, IL-17, IL-23
55/32 9
Ming H., 2019 China 30783447 IL-8 684/192 8
Tang T., 2019 China 30284175 IL-1β, IL-6, IL-18 120/127 7
Shi C., 2019 China 29453637 IL-2 15/15 8
Zhang D., 2019 China 30542936 IL-8 21/10 7
Bozic J., 2018 Croatia 29991422 IL-6 50/25 8
Kong Y., 2018 China 29843666 IL-1β, IL-6 50/40 5
Lu D., 2018 China 28707162 IL-6 35/22 6
Mônico-Neto M., 2018 Brazil 30093572 IL-6 447/211 5
Rogers V.E., 2018 US 29862666 IL-10, IL-12 20/7 5
Shalitin S., 2018 Israel 29305826 IL-6 9/29 6
Gamsiz-Isik H., 2017 Turkey 27858556 IL-1β 83/80 8
Jin F., 2017 China 28901415 IL-8 100/50 8
Said E.A., 2017 Oman 28830779 IL-2, IL-4, IL-8,
IL-10, IL-12
22/21 6
Smith D.F., 2017 US 28204724 IL-6, IL-8 65/90 5
Su M., 2017 China 28500380 IL-4, IL-10 42/48 7
Toujani S., 2017 Tunisia 28469721 IL-17 92/30 8
Zhang Z., 2017 China 28367199 IL-2, IL-4, IL-6, IL-10 50/52 5
Archontogeorgis K.,
2016
Greece 27843647 IL-8 64/20 7
Can M., 2016 Turkey 27665460 IL-23 12/27 6
Dogan D., 2016 Turkey 27346160 IL-6 39/12 8
Huang Y.S., 2016 China 27741107 IL-1β, IL-6, IL-10,
IL-17, IL-23
47/32 6
Ifergane G., 2016 Israel 27073238 IL-6 21/22 8
Nizam N., 2016 Turkey 26232894 IL-6 39/13 7
Zychowski K.E., 2016 US 27693879 IL-6 8/7 6
Damiani M.F., 2015 Italy 26697221 IL-6 30/30 7
Leon-Cabrera S., 2015 Mexico 25944984 IL-10, IL-12 29/13 6
Nobili Y., 2015 Italy 26069285 IL-6 52/28 8
Sarinc Ulasli S., 2015 Turkey 25724552 IL-2, IL-10 28/20 6
Ye J., 2015 China 25860501 IL-4, IL-17 25/19 8
Zhang S.W., 2015 China - IL-18 66/25 8
Ciccone M.M., 2014 Italy 24481114 IL-6 80/40 7
Gileles-Hillel Alex, 2014 US 24991089 IL-6 75/129 9
Akinnusi M., 2013 US 23239459 IL-4, IL-6, IL-8,
IL-10
25/18 8
Kurt O.K., 2013 Turkey 23783568 IL-6 48/37 7
Yang D., 2013 China 23567762 IL-6 25/25 7
Deboer M.D., 2012 US 21360253 IL-6 9/15 7
Medeiros C. A. M., 2012 Brazil 21916851 IL-1β, IL-6 50/15 7
Qian X., 2012 China 22527145 IL-6 30/40 6
Ye J., 2012 China 23345934 IL-6, IL-10, IL-17 44/20 9
Liu Z., 2011 China - IL-6 20/20 8
Kim J., 2010 Korea 20855682 IL-6, IL-8 37/22 6
Sahlman J., 2010 Finland 20040038 IL-1β, IL-6, IL-10 84/40 7
Steiropoulos P., 2010 Greece 20628509 IL-6 38/23 8
Ye L., 2010 China 20668869 IL-6 127/52 7
Li Y., 2009 China 18207457 IL-6, IL-10 68/22 7
Li C., 2009 China 19187612 IL-18 52/18 8
Antonopoulou S., 2008 Greece 18606530 IL-6 45/25 7
Arias M.A., 2008 Spain 18508832 IL-6 30/15 9
Constantinidis J., 2008 Greece 18317790 IL-1β, IL-6 13/12 7
Li Y., 2008 China 18311073 IL-6, IL-10 28/22 5
Nakra N., 2008 US 18762497 IL-6 24/9 7
Takahashi K.I., 2008 Japan 18199002 IL-6 41/12 7
Tomiyama H., 2008 Japan 18224268 IL-6, IL-1β 50/15 8
Chen J., 2007 China - IL-6 100/40 6
Tauman R., 2007 US 17171553 IL-6 78/33 8
Bao H.R., 2005 China - IL-8, IL-10 35/25 7
Ciftci T.U., 2004 Turkey 15381186 IL-6 43/22 6
Liu H., 2000 China 11215046 IL-6 22/16 6
Roytblat L., 2000 Israel 11225716 IL-6 11/9 5

IL, interleukin; P/C No., number of patients with OSA (P) and controls (C) in each group; NOS represents Newcastle-Ottawa Scale, which is used for article quality evaluation.

For the references for each study, please refer to Supplemental Table 2.